Update on Hydroxychloroquine Use in Pregnancy

Overview

Journal World J Exp Med

Publisher Baishideng Publishing Group

Specialty Biomedical Engineering

Date 2023 Sep 28

PMID 37767540

Authors

Wassan Nori

Nabeeha Najatee Akram

Raid M Al-Ani

Affiliations

Soon will be listed here.

Abstract

It is well-known that hydroxychloroquine (HCQ) treats malaria, systemic lupus erythematosus, and rheumatoid arthritis in women for its immunomodulatory and anti-inflammatory action. Additionally, HCQ was used in cases with refractory antiphospholipid syndrome. HCQ safety was reinforced in pregnant women owing to insignificant reports of adverse pregnancy outcomes and major congenital malformation. Recently, HCQ was tested in cases with chronic placental inflammation with a promising result of increased life birth; however, its benefit needs further validation. We aimed to highlight the recent updates for HCQ use in various conditions in pregnancy.

Citing Articles

Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy.

Basri N, Murthi P, Rahman R Int J Mol Sci. 2024; 25(17).

PMID: 39273629 PMC: 11395545. DOI: 10.3390/ijms25179681.

References

Choi E, Jeong H, Noh Y, Choi A, Yon D, Han J . Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: A nationwide cohort study. PLoS Med. 2023; 20(2):e1004183. PMC: 9970080. DOI: 10.1371/journal.pmed.1004183. View

Saraiva-Mangolin S, de Oliveira Vaz C, Ruiz T, Moraes Mazetto B, Orsi F . Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome. Eur J Intern Med. 2021; 90:114-115. DOI: 10.1016/j.ejim.2021.05.025. View

Do S, Rizk N, Druzin M, Simard J . Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies?. Am J Perinatol. 2020; 37(9):873-880. DOI: 10.1055/s-0039-3402752. View

Liu J, Zhang L, Tian Y, Wan S, Hu M, Song S . Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome. J Cell Mol Med. 2022; 26(15):4357-4370. PMC: 9344817. DOI: 10.1111/jcmm.17459. View

Cornish E, McDonnell T, Williams D . Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome. Front Immunol. 2022; 13:825075. PMC: 9072631. DOI: 10.3389/fimmu.2022.825075. View

Urbanski G, Caillon A, Poli C, Kauffenstein G, Begorre M, Loufrani L . Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome. PLoS One. 2018; 13(11):e0206814. PMC: 6219787. DOI: 10.1371/journal.pone.0206814. View

Bouariu A, Gica N, Ciobanu A, Scutelnicu A, Popescu M, Panaitescu A . The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes. Healthcare (Basel). 2022; 10(1). PMC: 8775717. DOI: 10.3390/healthcare10010168. View

Farhan F, Nori W, Al Kadir I, Hameed B . Can Fetal Heart Lie? Intrapartum CTG Changes in COVID-19 Mothers. J Obstet Gynaecol India. 2022; 72(6):479-484. PMC: 9128777. DOI: 10.1007/s13224-022-01663-6. View

Hu Z, Gao R, Huang W, Wang H, Qin L . Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2023; 12(2). PMC: 9866542. DOI: 10.3390/jcm12020485. View

10.

Bajpai J, Pradhan A, Verma A, Kant S . Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection. World J Exp Med. 2022; 12(3):44-52. PMC: 9168786. DOI: 10.5493/wjem.v12.i3.44. View

11.

Dong Y, Lu Y, Xia Y, Wang X . Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis. J Matern Fetal Neonatal Med. 2021; 35(25):7084-7092. DOI: 10.1080/14767058.2021.1943656. View

12.

Brady C, Williams C, Batra G, Church E, Tower C, Crocker I . Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis. Front Med (Lausanne). 2021; 8:753220. PMC: 8558526. DOI: 10.3389/fmed.2021.753220. View

13.

Clowse M, Eudy A, Balevic S, Sanders-Schmidler G, Kosinski A, Fischer-Betz R . Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data. Lupus Sci Med. 2022; 9(1). PMC: 8935175. DOI: 10.1136/lupus-2021-000651. View

14.

Sammaritano L, Bermas B, Chakravarty E, Chambers C, Clowse M, Lockshin M . 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020; 72(4):529-556. DOI: 10.1002/art.41191. View

15.

Berard A, Sheehy O, Zhao J, Vinet E, Quach C, Bernatsky S . Chloroquine and Hydroxychloroquine Use During Pregnancy and the Risk of Adverse Pregnancy Outcomes Using Real-World Evidence. Front Pharmacol. 2021; 12:722511. PMC: 8366774. DOI: 10.3389/fphar.2021.722511. View

16.

Huybrechts K, Bateman B, Zhu Y, Straub L, Mogun H, Kim S . Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2020; 224(3):290.e1-290.e22. PMC: 7501839. DOI: 10.1016/j.ajog.2020.09.007. View

17.

Ye S, Zhao X, Liu Y, Ma Y, Wang Y, Zhao J . The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities. Clin Rheumatol. 2022; 42(4):1137-1150. DOI: 10.1007/s10067-022-06462-y. View